Skip to content
healthcare.dev

Tadalafil

NDC 70954-434, Tadalafil, tablet, from ANI Pharmaceuticals, Inc..

Product NDC
70954-434
Status
Listed
Labeler
ANI Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215949
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70954-434 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TADALAFIL10 mg/1

Pharmacologic classes

Phosphodiesterase 5 Inhibitor [EPC]; Phosphodiesterase 5 Inhibitors [MoA]

Package NDCNDC-11Package
70954-434-107095404341030 TABLET in 1 BOTTLE (70954-434-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1dace1e7-c617-492f-bb0d-141bf4e673db

Use it

Look up 70954-434 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70954-434 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70954-434. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.